CLINICAL_TRIALS
research
· 2025-12-16
Clinical Trial Update: A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. [Phase 1, Phase 2]
Summary
APG-2575 is being studied in Phase 1 and Phase 2 trials for mild-to-moderate systemic lupus erythematosus, with recruitment ongoing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ascentage Pharma Group Inc. | Conditions: SLE | Phase 1, Phase 2 | Status: RECRUITING